Sai Life Sciences Limited announced that ICRA Limited has assigned new credit ratings for its various financing instruments. The long-term fund-based facilities have been rated [ICRA] AA (Stable), while the short-term non-fund-based facilities received an [ICRA] A1+ rating. The total facilities rated amount to Rs. 768.60 Crore. These ratings reflect the strength of the company’s debt servicing capability and the underlying financial commitments across its banking partners as of February 26, 2026.
Credit Rating Update for Financing Instruments
On February 26, 2026, Sai Life Sciences Limited received updated credit ratings from ICRA Limited for its outstanding banking facilities. This intimation follows the standard regulatory disclosures regarding the company’s creditworthiness.
The key ratings assigned by ICRA are as follows:
- Long Term – Fund Based – Others: Rs. 550.00 Crore rated [ICRA] AA (Stable).
- Short Term – Non-Fund Based – Others: Rs. 218.60 Crore rated [ICRA] A1+ (Stable).
- The total aggregate rated amount stands at Rs. 768.60 Crore.
Details of Rated Bank Limits
The comprehensive annexure detailed the allocation of these ratings across various specific bank limits, all assigned on February 25, 2026. The long-term facilities (rated [ICRA] AA (Stable)) aggregated Rs. 550.00 Crore, with major allocations to State Bank of India (Rs. 155.00 Crore) and Indusind Bank Limited (Rs. 96.00 Crore).
The short-term facilities (rated [ICRA] A1+) covered non-fund-based facilities and derivative limits, totaling Rs. 218.60 Crore. Notable short-term non-fund-based limits included State Bank of India (Rs. 70.00 Crore) and Indusind Bank Limited (Rs. 43.00 Crore).
Rating Surveillance and Obligation
ICRA noted that these ratings will be subject to surveillance review within one year from the communication date. The rating agency reserves the right to review or revise the ratings based on new information or changes in the terms or size of the underlying instruments. Furthermore, the company is obligated to inform ICRA immediately of any default, delay in repayment, or any significant development impacting its ability to service its debt or raise further funds.
Source: BSE
